CIK 0001844417
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Estrella Immunopharma, Inc.
Sign in to watch- Ticker
- ESLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 861314502
- Phone
- +1 510-318-9098
- Business address
- 5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
- Former names
- TradeUP Acquisition Corp.
Securities
- ESLA Common Stock Nasdaq
- ESLAW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-25 | Liu Cheng CEO | Exercise or conversion | +100,000 | $0.82 | $82K | 397,437 |
| 2026-08-25 | Liu Cheng CEO | Exercise or conversion · Incentive Stock Option | +100,000 | 900,000 | ||
| 2024-10-30 | Liu Cheng Chief Executive Officer | Grant or award · Incentive Share Option | +490,796 | 490,796 | ||
| 2024-10-30 | Liu Cheng Chief Executive Officer | Grant or award · Nonstatutory Share Option | +509,204 | 509,203 |
Page 1 of 1 · 4 trades